A patient diagnosed with C. difficile infection is considered a high risk for recurrence. Which medication will the provider prescribed?

Question

Quizplus · Accepted Answer

Bezlotoxumab is specifically indicated to reduce the recurrence of Clostridium difficile infection (CDI) in patients who are at high risk for CDI recurrence. It is a monoclonal antibody that targets the C. difficile toxin B, preventing its effects. The other options are monoclonal antibodies used for different indications, not for C. difficile infection.

A Patient Diagnosed with C